Rights issue of SEK 121m; subscription period: 12-26 Oct. Use of proceeds could finance operations well into '25. 67% dilution; new fair value range of SEK 2-5 (3-10).


Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Update on capital raise
Nanexa AB (NANEXA:OME) | 0 0 0.0%
- Published:
02 Oct 2023 -
Author:
ABGSC Healthcare Research | Gonzalo Artiach | Alexander Krämer -
Pages:
9 -
Rights issue of SEK 121m; subscription period: 12-26 Oct. Use of proceeds could finance operations well into '25. 67% dilution; new fair value range of SEK 2-5 (3-10).